- LivaNova to Announce First-Quarter 2024 Results
- LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea
- LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029
- LivaNova to Present at the Barclays Global Healthcare Conference
- LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
- LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director
More ▼
Key statistics
As of last trade LivaNova PLC (LIVN:NSQ) traded at 54.59, -8.81% below its 52-week high of 59.86, set on Jul 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 55.37 |
---|---|
High | 55.84 |
Low | 54.27 |
Bid | 54.61 |
Offer | 54.69 |
Previous close | 55.94 |
Average volume | 602.51k |
---|---|
Shares outstanding | 53.96m |
Free float | 53.68m |
P/E (TTM) | 173.60 |
Market cap | 3.02bn USD |
EPS (TTM) | 0.3222 USD |
Data delayed at least 15 minutes, as of Apr 25 2024 16:00 BST.
More ▼